There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.
The FDA Drug Labels for ibuprofen (PO) do not address this question.
From the Research
Ibuprofen Safety in Patients with Coronary Stent Placement and Chronic Heart Disease
- There is no direct evidence in the provided studies regarding the safety of ibuprofen in patients with a history of coronary stent placement and chronic heart disease post-tooth extraction.
- However, studies have investigated the safety of continuing antiplatelet therapy, such as aspirin and clopidogrel, during dental procedures like tooth extraction in patients with coronary stent placement 1, 2, 3.
- One study found that most dental extractions can be carried out safely without stopping multiple antiplatelet agents in coronary stenting patients, with no cases of transfusion, rehospitalization for bleeding, or major cardiovascular events 2.
- Another study concluded that using aspirin and clopidogrel simultaneously has no considerable effect on the risk of bleeding in patients having conventional forceps extraction of a single tooth 3.
- The management of patients with coronary stent placement and chronic heart disease undergoing dental procedures should be based on individual risk assessment and consultation with the patient's cardiologist or primary care physician, as suggested by studies on antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting 4.
- It is essential to note that ibuprofen is an anti-inflammatory medication that may increase the risk of bleeding when used with antiplatelet agents, and its safety in this context is not directly addressed in the provided studies 1, 5, 4, 2, 3.